COVID-19

The vaccine is 91.3% effective against COVID-19 for up to 6 months after the second dose, according to an analysis of data collected through March 13.

Pfizer/BioNTech released data on their COVID-19 vaccine that indicates high efficacy in children aged 12 to 15 years.

A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.

A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.

Here’s a roundup of the latest coronavirus-related news.

The updated analyses of the AZD1222 COVID-19 vaccine will be submitted to the FDA for emergency use authorization, according to AstraZeneca.

A recent study looked at the role of the influenza vaccine in COVID-19 susceptibility and severity

AstraZeneca responded to the concerns by promising to release the most up-to-date data within 48 hours.

Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose.

AstraZeneca is preparing to submit its COVID-19 vaccine data to the FDA for emergency use authorization in the coming weeks.

The CDC reported data demonstrating high adherence to COVID-19 vaccine doses among recipients.

Here’s a roundup of the latest coronavirus-related news.

Survey results suggest independent pharmacies may be better positioned than chains to offer COVID-19 POC testing to their patients.

Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.

Watch this virtual tour of Tulane University's self-care resources website with Patrick Bordnick, dean of the School of Social Work.

Germany, Spain, Ireland, and France, among other EU countries, have decided to temporarily suspend the AstraZeneca COVID-19 vaccine amid reports of serious cases of blood clots.

Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves

NCPA lauded the higher reimbursement rate in a statement.

Hospitals employ several strategies for a proactive approach to shortages.

An update on COVID-19 advocacy activity and regulations affecting your pharmacy practice.

Here’s a roundup of the latest coronavirus-related news.

New survey results released by NCPA suggest that many Americans prefer to receive the COVID-19 vaccine from a local health care provider over a mass vaccination event.

The CDC has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for COVID-19.

In an opinion piece, pharmacist Pete Kreckel highlights the ways that women have been leading the COVID-19 vaccination effort.

Here's a roundup of the latest coronavirus-related news.

In a briefing this morning, the Infectious Diseases Society of America (IDSA) stressed the continued importance of COVID-19 control measures that have been there from the start.

Jon Copeland, president of AAP, joins Drug Topics® in this episode of Over the Counter to discuss key pharmacy industry trends, including digital health, the Amazon effect, PBM accountability, and pharmacy cooperatives.

President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May.

Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.

The FDA is allowing more flexible storage and transportation conditions for Pfizer-BioNTech’s COVID-19 vaccine.